Professional Documents
Culture Documents
Generic Name/Trade Name Dosage/ Frequency Classfication Side Effect Indications Contraindications Nursing Responsibilities
Generic Name/Trade Name Dosage/ Frequency Classfication Side Effect Indications Contraindications Nursing Responsibilities
Monitor if
platelet
count is
less than
150,000/
mm3;
drug is
usually
discontin
ued and
another
drug
started.
Monitor for
adverse
reactions:
CNS:
headache
GI:
diarrhea,
abdominal
pain,
nausea,
vomiting,
constipatio
n and dry
mouth.
Assess
patient’s
and
family’s
knowledge
of drug
therapy.
Check for
baseline in
renal, liver
function
tests
before
therapy
begins.
Assess for
edema in
feet, legs
daily;
monitor
input-
output
ratio, daily
weight;
check for
jugular
vein
distention,
rales
bilaterally,
dyspnea.
Generic Dosage/ Classification Side Effect Indications Contraindications Nursing
Name/Trade Frequency Responsibilities
Name
20mg/tab GI disturbances. Hypercholest Hypersensitivity to Document
Atorvastatin OD antihyperlipide Headache, erolemia: any component of indications
mic, HMG-CoA myalgia, Adjunct to this medication. for
reductase asthenia, diet to Active liver disease therapy,
inhibitor
insomnia; reduce or unexplained onset and
angioneurotic elevated total persistent duration of
edema. Muscle cholesterol, elevations of serum illness,
cramps, LDL transaminases other
myositis, cholesterol, exceeding 3x the medication
myopathy, Apolipoprotei upper limit of s taken.
cholestatic n B, and normal.
jaundice; triglycerides Monitor
peripheral levels. cholesterol
neuropathy; ,
pruritus. tryglycerri
des and
liver
function
tests
before
therapy
and
reassess
regularly.
Assess
nutrition
and
dietary
habits:
weight,
exercise
habits,
lifestyle
and
complete
nutritional
analysis.
Assess for
muscle
pain,
tendernes
s, obtain
CPK if
these
occur,
drug may
need to be
discontinu
ed.
Monitor
bowel
pattern
daily;
diarrhea
may be a
problem.
Assess
patient’s
and
family’s
knowledge
on drug
therapy.
For patient
with
hepatic
encephalo
pathy,
regularly
assess
mental
condition
ammonia
level.
Monitor for
possible
adverse
GI
reaction:
nausea,
vomiting,
abdominal
cramps,
belching,
diarrhea,
flatulence,
and
distention.
Monitor
fluid and
electrolyte
status:
Urine
output,
input-
output
ratio to
identify
fluid loss,
hypokalem
ia, and
hyperbatre
mia.
Monitor for
increased
glucose
levels in
diabetic
patients.
Assess
patient’s
and
family’s
knowledge
of drug
therapy.